Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazilian Medicine Angioplasty or Surgery Study (MASS) finds little difference between angina therapies:

This article was originally published in Clinica

Executive Summary

Bypass surgery patients were less likely to need revascularisation than those treated by PTCA or medication in the Brazilian Medicine Angioplasty or Surgery Study (MASS). None of the bypass patients needed revascularisation during a three-year follow-up period. All three strategies eventually eradicating limiting-angina but bypass and angioplasty gave greater initial relief and better treadmill test scores. There was no difference in mortality or infarction rates, says Dr Whady Hueb, writing in the Journal of the American College of Cardiology (December).

Topics

UsernamePublicRestriction

Register

MT094574

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel